BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1750299)

  • 1. [Morphologic studies of endometrial cancer for biological assessment of nuclear grading].
    Köhler U
    Zentralbl Gynakol; 1991; 113(18):995-1003. PubMed ID: 1750299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
    Köhler U; Krug H; Taubert G
    Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen.
    Garzetti GG; Ciavattini A; Goteri G; Tranquilli AL; Muzzioli M; Fabris N; De Nictolis M; Romanini C
    Gynecol Oncol; 1994 Oct; 55(1):111-4. PubMed ID: 7525425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphologic prognostic criteria in endometrial cancer with special reference to nuclear grading].
    Schneider ML
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):267-77. PubMed ID: 3721157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of prognostic factors in patients with endometrial cancer and lymph node excision].
    Vavra N; Sevelda P; Schemper M; Kucera H; Weghaupt K
    Gynakol Rundsch; 1991; 31 Suppl 2():258-60. PubMed ID: 1790946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
    Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
    Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
    Yin LJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative platelet count as index of the grading in endometrial carcinoma].
    Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM
    Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myometrial invasion as a prognostic factor in endometrial adenocarcinoma].
    Mihalcea D; Aursulesei D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):136-9. PubMed ID: 21495308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors and results of treatment in endometrial carcinoma].
    Grulich D; Hagen A; Morack G
    Zentralbl Gynakol; 1996; 118(3):154-63. PubMed ID: 8900605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
    Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters.
    Yura Y; Tauchi K; Koshiyama M; Konishi I; Yura S; Mori T; Matsushita K; Hayashi M; Yoshida M
    Gynecol Oncol; 1996 Oct; 63(1):114-9. PubMed ID: 8898179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.